Open AccessVenetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia
Author(s) -
Carsten Utoft Niemann,
MarkDavid Levin,
Julie Dubois,
Sabina Kersting,
Lisbeth Enggaard,
G.J. Veldhuis,
Rogier Mous,
Clemens Mellink,
Johan A. Dobber,
Christian Bjørn Poulsen,
Henrik Frederiksen,
Ann Janssens,
Ida Schjødt,
Ellen C. Dompeling,
Juha Ranti,
Mattias Mattsson,
Mar Bellido,
Hoa Tran,
Kazem Nasserinejad,
Ar P. Kater
Publication year - 2020
Publication title -
blood
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.515
H-Index - 465
eISSN - 1528-0020
pISSN - 0006-4971
DOI - 10.1182/blood.2020008608
Subject(s) - ibrutinib , venetoclax , chronic lymphocytic leukemia , medicine , refractory (planetary science) , oncology , leukemia , physics , astrobiology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom